Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
instead of mgt being paid millions, they should have inventory of product ready to go
10 people getting 2 treatments per week does not cost cydy much at all to produce
40 treatments over 2 weeks is not a big budget for cydy to handle
just my opinion
mgt is trying to make a buck, read the filings
by the time cydy gets through the fda process, covid-19 will be long gone
it certainly appears to be that
the federal government just announced they bought millions of dollars of another drug, so you may want to watch Trump daily briefings for that information
btw, at this point we wont see any orders for a non fda approved treatment
cydy hopes rest with fda approval as they have nothing to sell other than their story of hope that np has on display with daily home videos
if you really did research on the company you might not be so bullish
what happened to the 30 million dollar purchase order? did cydy not pay for that order?
perhaps cydy should disclose inventory of leronlimab
most public companies do that!
how much product is made ready for use?
looks like lack of transparency by cydy
thank you for the good clarification
i cant find it
could that be the reason fox canceled interview?
interesting info
he is till liable for board actions taken before his resignation date
in my opinion all cydy shareholders will see the self enrichment plan that the board approved
probably concerned about future liability
other drugs already exist for that
i agree 100%
i doubt very much the cydy will be supplying the world, due your homework as many other companies ahead of cydy's 10 people test
you are correct 100%
under $300 by may
we agree, fell out of my chair
bk coming, total disaster
SECTION 11 OWNERSHIP OF MATERIALS AND INTELLECTUAL PROPERTY
11.3.2
SBL Invention. Any Invention that [***], shall be the property of SBL (“SBL Invention”), and shall not be deemed to be Client Invention or Joint Invention for the purposes of the MSA.
GOOD LUCK CYDY SHAREHOLDERS
e. Product Purchase Commitment.
lots of ???'s
has cydy honored this agreement?
https://www.sec.gov/Archives/edgar/data/1175680/000119312519221300/d40614dex1012.htm
company takes in toxic money, with no regard to shareholders
stock has zero chance to recover
thank you for the insight; 2012 to 2020 and no commercialization? what is going on here?
this is a very interesting update
maybe all shareholders should be as informed as you are
i don't think this gets discussed in the videos, does it?
it would never go bk first, because samsung could go file a lawsuit if cydy is in default of the agreement
does anyone have a copy of the agreement ?
A DEFAULT BY CYDY ON THE SAMSUNG AGREEMENT COULD MEAN STOCK GOING MUCH MUCH LOWER
THANK YOU FOR THE GREAT INSIGHT AND UPDATE
ESSENTIALLY, SAMSUNG COULD OWN THE SUCCESS IF ANY ON LERONLIMAB AND CYDY SHAREHOLDERS GET NOTTA
I AGREE AND DISAGREE, I HOPE NO MORE DEATHS HAPPEN, REGARDLESS OF WHAT DRUG IS APPROVED
tv stations dont control the FDA
i doubt big pharma will get beat out by an otc company, why the delay at fda for so many years?
just my opinion as are all my posts
you a smart investor compared to most posting here
just be careful company does not go BK or reverse split
clarification from np would be good
why would any ceo enter into such a contract until fda approval?
looks like a very dumb move
my thoughts are based on due diligence and so far the company seems to have the general public drinking the cool-aid
with all the volume last week this stock should be at $50, but somebody is selling stock very aggressively
that is a great point
thank you for the great update